These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10294441)

  • 1. Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
    Bowman MA; Pearle DL
    J Contin Educ Health Prof; 1988; 8(1):13-20. PubMed ID: 10294441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
    Orlowski JP; Wateska L
    Chest; 1992 Jul; 102(1):270-3. PubMed ID: 1623766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal.
    Rodwin MA
    J Law Med Ethics; 2010; 38(4):807-15. PubMed ID: 21105944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician development initiative: small group CME.
    Holland DS; Defontes J; Klau M; Bruss J; Lehmer R; Sultan M; Brody MR
    HMO Pract; 1997 Dec; 11(4):182-4. PubMed ID: 10176522
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of sponsored and unsponsored continuing medical education].
    Chon SH; Lösche P; Christ H; Lehmacher W; Griebenow R
    Med Klin (Munich); 2008 May; 103(5):341-5. PubMed ID: 18484220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey.
    Tabas JA; Boscardin C; Jacobsen DM; Steinman MA; Volberding PA; Baron RB
    Arch Intern Med; 2011 May; 171(9):840-6. PubMed ID: 21555662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industry-sponsored grand rounds and prescribing behavior.
    Dieperink ME; Drogemuller L
    JAMA; 2001 Mar; 285(11):1443-4. PubMed ID: 11255418
    [No Abstract]   [Full Text] [Related]  

  • 10. Commercial Interests in Continuing Medical Education: Where Do Electronic Health Record Vendors Fit?
    Rubinstein PF; Middleton B; Goodman KW; Lehmann CU
    Acad Med; 2020 Nov; 95(11):1674-1678. PubMed ID: 32079950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program.
    Campbell NR; McAlister FA; Brant R; Levine M; Drouin D; Feldman R; Herman R; Zarnke K;
    J Hypertens; 2003 Aug; 21(8):1591-7. PubMed ID: 12872055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How conducting a clinical trial affects physicians' guideline adherence and drug preferences.
    Andersen M; Kragstrup J; Søndergaard J
    JAMA; 2006 Jun; 295(23):2759-64. PubMed ID: 16788131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of family physicians and psychiatrists. Psychotropic prescribing practices and educational needs.
    Tinsley JA; Shadid GE; Li H; Offord KP; Agerter DC
    Gen Hosp Psychiatry; 1998 Nov; 20(6):360-7. PubMed ID: 9854648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.
    Stafford RS; Monti V; Furberg CD; Ma J
    Hypertension; 2006 Aug; 48(2):213-8. PubMed ID: 16785334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
    Stafford RS; Furberg CD; Finkelstein SN; Cockburn IM; Alehegn T; Ma J
    JAMA; 2004 Jan; 291(1):54-62. PubMed ID: 14709576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do physicians and trainers experience outcome-based education in "Rational prescribing"?
    Esmaily HM; Vahidi R; Fathi NM; Wahlström R
    BMC Res Notes; 2014 Dec; 7():944. PubMed ID: 25533194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quest of prescribing practice in Pakistan.
    Shiwani MH
    J Pak Med Assoc; 2006 May; 56(5):249-50. PubMed ID: 16767958
    [No Abstract]   [Full Text] [Related]  

  • 19. Commercial support of continuing medical education in the United States: the politics of doubt, the value of studies.
    Mazmanian PE
    J Contin Educ Health Prof; 2009; 29(2):81-3. PubMed ID: 19530200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.